Our Technology
A leader in antibody drugs in China with capabilities in research and development, manufacturing and commercialization.
Our Technology
A leader in antibody drugs in China with capabilities in research and development, manufacturing and commercialization.
New Drug R&D
Sunshine Guojian has 3 listed products and 14 products under development.
The company has a specialized antibody drug development platform and provides technical and intellectual resources to support the 「National Engineering Research Center of Antibody Medicine.」 The R&D team has more than 200 employees, with more than 45% of researchers having Master’s degree and above. It owns more than 50 patents and has undertaken 18 state-level major projects including 「863 Program」 and 「National Major New Drug Development.」
-
200+
The R&D team has more than 200 employees.
-
17
3 listed products
14 products under development
-
50+
Owns more than 50 patents
-
18
Undertaken 18 state-level major projects
Our Technology
A leader in antibody drugs in China with capabilities in research and development, manufacturing and commercialization.
Our Technology
A leader in antibody drugs in China with capabilities in research and development, manufacturing and commercialization.
New Drug R&D
Sunshine Guojian has 3 listed products and 14 products under development.
The company has a specialized antibody drug development platform and provides technical and intellectual resources to support the 「National Engineering Research Center of Antibody Medicine.」 The R&D team has more than 200 employees, with more than 45% of researchers having Master’s degree and above. It owns more than 50 patents and has undertaken 18 state-level major projects including 「863 Program」 and 「National Major New Drug Development.」
-
200+
The R&D team has more than 200 employees.
-
17
3 listed products
14 products under development
-
50+
Owns more than 50 patents
-
18
Undertaken 18 state-level major projects